In a feature report highlighting global attempts to combat Covid-19, the FLARE trial led by Professor David Lowe (UCL Institute of Immunity & Transplantation), which aims to see if favipiravir and lopinavir/ritonavir can inhibit viral replication in early infection, is mentioned.
Read: The Observer
Close
